Comparison between Medicamen Organics IPO and Shivalic Power Control IPO.
Medicamen Organics IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Shivalic Power Control IPO is a SME Bookbuilding proposed to list at NSE SME.
| Medicamen Organics IPO | Shivalic Power Control IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | GYR Capital Advisors Pvt.Ltd. | Corporate Capitalventures Pvt.Ltd. |
| Registrar | Kfin Technologies Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | Giriraj Stock Broking Pvt.Ltd. | SS Corporate Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Medicamen Organics IPO is up to ₹9.96 Cr whereas the issue size of the Shivalic Power Control IPO is up to ₹60.96 Cr. The final issue price of Medicamen Organics IPO is ₹34.00 per share and of Shivalic Power Control IPO is ₹100.00 per share.
| Medicamen Organics IPO | Shivalic Power Control IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹32.00 per share | ₹95.00 per share |
| Issue Price (Upper) | ₹34.00 per share | ₹100.00 per share |
| Issue Price (Final) | ₹34.00 per share | ₹100.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 4000 shares | 1200 shares |
| Fresh Issue Size | 29,28,000 shares | 60,96,000 shares |
| Fresh Issue Size (Amount) | up to ₹9.96 Cr | up to ₹60.96 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 29,28,000 shares | 60,96,000 shares |
| Issue Size Total (Amount) | up to ₹9.96 Cr | up to ₹60.96 Cr |
Medicamen Organics IPO opens on Jun 21, 2024, while Shivalic Power Control IPO opens on Jun 24, 2024. The closing date of Medicamen Organics IPO and Shivalic Power Control IPO is Jun 25, 2024, and Jun 26, 2024, respectively.
| Medicamen Organics IPO | Shivalic Power Control IPO | |
|---|---|---|
| Anchor Bid Date | Jun 20, 2024 | Jun 21, 2024 |
| Issue Open | Jun 21, 2024 | Jun 24, 2024 |
| Issue Close | Jun 25, 2024 | Jun 26, 2024 |
| Basis Of Allotment (Tentative) | Jun 26, 2024 | Jun 27, 2024 |
| Initiation of Refunds (Tentative) | Jun 27, 2024 | Jun 28, 2024 |
| Credit of Share (Tentative) | Jun 27, 2024 | Jun 28, 2024 |
| Listing date (Tentative) | Jun 28, 2024 | Jul 01, 2024 |
| Anchor Lockin End date 1 | Jul 26, 2024 | Jul 27, 2024 |
| Anchor Lockin End date 2 | Sep 24, 2024 | Sep 25, 2024 |
Medicamen Organics IPO P/E ratio is 30.53, as compared to Shivalic Power Control IPO P/E ratio of 24.69.
| Medicamen Organics IPO | Shivalic Power Control IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 81.21 | 96.63 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 70.86 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 30.53 | 24.69 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹39.78 Cr. | ₹241.16 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 19.90% | 28.33% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 14.50% | 19.20% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.83 | 1.09 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹1.11 | ₹4.05 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 15.83 | 28.33% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Medicamen Organics IPO Retail Individual Investors (RII) are offered 10,28,000 shares while in Shivalic Power Control IPO retail investors are offered 10,28,000 shares. Qualified Institutional Buyers (QIB) are offered 5,84,000 shares in Medicamen Organics IPO and 12,19,200 shares in Shivalic Power Control IPO.
| Medicamen Organics IPO | Shivalic Power Control IPO | |
|---|---|---|
| Anchor Investor Reservation | 8,76,000 shares | 18,28,800 shares |
| Market Maker Reservation | 1,72,000 shares | 3,36,000 shares |
| QIB | 5,84,000 shares | 12,19,200 shares |
| NII | 4,40,000 shares | 9,14,400 shares |
| RII | 10,28,000 shares | 21,33,600 shares |
| Employee | ||
| Others | ||
| Total | 29,28,000 shares | 60,96,000 shares |
Medicamen Organics IPO subscribed 993.56x in total, whereas Shivalic Power Control IPO subscribed 257.24x.
| Medicamen Organics IPO | Shivalic Power Control IPO | |
|---|---|---|
| QIB (times) | 173.03x | 170.32x |
| NII (times) | 1,343.83x | 436.37x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1,309.77x | 230.14x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 993.56x | 257.24x |
